Since CSC markers, LGR5 and NANOG have been shown to be progressively expressed during carcinogenesis and promote cancer cell proliferation and tumor formation [22,39], we next evaluated the impact of PCs repression in tumor cells on LGR5 and NANOG expression during tumor progression. The gene discussed is NANOG; the disease is neoplasm.